Comentário do KDOQI US sobre a Diretriz KDIGO 2021 para o tratamento da pressão arterial na doença renal crônica.
25 Jan, 2022 | 11:29hConteúdos relacionados:
Comentário no Twitter
The @nkf KDOQI work group agreed with most of the @goKDIGO BP recommendations while highlighting the weak evidence base especially for patients with diabetes and advanced CKD ca. 2022 #Nephpearls
👉🏼 https://t.co/X40N0pacY6 https://t.co/HEHlSD06yO pic.twitter.com/Rpil8m0QOn
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) January 21, 2022